Bibliographic Details
| Title: |
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer. |
| Authors: |
Weisman M; Department of Radiation Oncology, Indiana University School of Medicine., Durm G; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Shields MD; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Hanna NH; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Althouse S; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana., Lautenschlaeger T; Department of Radiation Oncology, Indiana University School of Medicine. Electronic address: timlaut@iu.edu. |
| Source: |
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Mar 01; Vol. 121 (3), pp. 720-727. Date of Electronic Publication: 2024 Oct 26. |
| Publication Type: |
Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: |
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
